Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
16.00
1.88%
After-hours: Aug 15, 2025, 07:56 PM EDT
Syndax Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M | -27.72M |
Depreciation & Amortization | 55K | 112K | n/a | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 8K | 11K | 11K | 10K | 8K | 9K | 16K |
Stock-Based Compensation | 13.79M | 10.38M | 12.3M | 11.93M | 9.9M | 8.9M | 8.33M | 8.32M | 8.06M | 6.24M | 4.24M | 4.36M | 3.94M | 3.48M | 3.93M | 3.38M | 3.24M | 2.77M |
Other Working Capital | n/a | -3.58M | 26.46M | 10.82M | -4.88M | -9.56M | 22.1M | 6.52M | 1.82M | -4.19M | 16.73M | 1.96M | -4.88M | -10.84M | 715K | -9.59M | -1.88M | -998K |
Other Non-Cash Items | -29.79M | -20.81M | -2.7M | -2.76M | 11.69M | 12.24M | -10.59M | 237K | 149K | -3.86M | -1.91M | -145K | 258K | 22K | -472K | 228K | 216K | 215K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 7.38M | -3.66M | -3.72M | n/a | n/a | n/a | n/a | n/a | -218K | 173K | 187K | 113K |
Change in Working Capital | n/a | n/a | 27.19M | 12.63M | -10.07M | -16.47M | 26.01M | 1.59M | 4.75M | -486K | 13.97M | 2.63M | -6.67M | -8.27M | 1.26M | -8.1M | -4.79M | 2.02M |
Operating Cash Flow | -87.8M | -95.16M | -57.39M | -62.32M | -71.64M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.71M | -24.94M | -24.05M | -22.59M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -225K | n/a | n/a | -129K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -91.71M | -10.54M | -376.31M | -13.35M | n/a | -167.38M | -129.29M | -82.72M | -81.01M | -61.59M | -250.88M | -79.83M | -122.37M | -42.27M | -105.23M | -62.94M | -59.82M | -66.73M |
Sales Maturities Of Investments | 133.6M | 104.68M | 107.34M | 100.2M | 61.75M | 67.99M | 113M | 122.8M | 154.91M | 81.5M | 113.25M | 72.82M | 72.42M | 50.45M | 45.4M | 89.58M | 81.5M | 37.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 61.75M | -99.4M | -16.29M | 40.08M | 73.91M | 19.91M | -137.63M | 225K | -49.95M | 8.18M | -59.83M | 26.63M | 21.68M | -29.23M |
Investing Cash Flow | 41.89M | 94.14M | -268.97M | 86.85M | 61.75M | -99.4M | -16.29M | 40.08M | 73.91M | 19.91M | -137.63M | -6.79M | -49.95M | 8.18M | -59.96M | 26.63M | 21.68M | -29.23M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 551K | 930K | 347.43M | 3.1M | 676K | 2.17M | 389K | 1.85M | 1.32M | 2.47M | 1.14M | -13.53M | 21.72M | 557K | 28.57M | 1.71M | 889K | 960K |
Financial Cash Flow | 551K | 930K | 347.43M | 3.1M | 676K | 2.17M | 258.48M | 1.85M | 1.32M | 2.47M | 163.5M | -13.53M | 21.72M | 557K | 109.78M | 1.71M | 6.02M | 960K |
Net Cash Flow | -45.36M | -90K | 21.06M | 27.84M | -9.22M | -180.78M | 200.84M | -2.73M | 39.86M | -16.84M | 2.98M | -48.86M | -68.53M | -33.19M | 150.53M | 3.39M | 3.65M | -50.86M |
Free Cash Flow | -87.8M | -95.16M | -57.39M | -62.32M | -71.64M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.77M | -40.31M | -41.93M | 100.58M | -24.94M | -24.05M | -22.59M |